Vonage Expands Developer Ecosystem to Accelerate the Next Era of Enterprise Digital Transformation

19.2.2026 10:08:00 CET | Business Wire | Press release

Vonage verified Postman workspace extends reach by 40+ million developers; MCP servers and Startup Program among resources designed to further accelerate time-to-value for developers and enterprises

Vonage, part of Ericsson (NASDAQ: ERIC), today announced a number of new initiatives, to further expand and enable its global developer community. By growing its developer community and tools, giving developers and enterprises access to new mobile network insights and capabilities that can be embedded into existing applications and workflows, Vonage is accelerating its strategy to transform mobile networks into a programmable platform.

Putting Vonage APIs in the Hands of 40 million+ More Developers

Vonage is announcing the launch of its Verified Workspace on the Postman API Network, making Vonage APIs available to the 40+ million developers who use Postman. The new, verified workspace gives Postman’s community of global developer members certified access to Vonage’s portfolio of Network APIs, Communications APIs, and developer tools - enabling them to copy, or fork, collections into their own workspaces and build, test, and collaborate in real time with other developers and teams. This enables enterprise and self-serve developers to explore APIs more easily, get started faster, and scale securely, simplifying the onboarding experience and significantly reducing time-to-value.

“Vonage offers a wide range of Network and Communications APIs, and their verified presence on the Postman API Network gives developers a trusted, first-party source they can rely on,” said Noah Schwartz, Head of Product, Postman API Network. “By bringing official APIs, real examples, and MCP servers together, Vonage makes it possible for developers and their coding agents to move from exploration to integration in minutes.”

As a Postman Verified Publisher, Vonage and its network and communications APIs are now available across the Postman API Network, including:

Network APIs:Identity Insights, Verify, Silent Authentication and SIM Swap API
Communications APIs:Voice, Video, and Messages (including SMS, WhatsApp, and RCS)

Leveraging AI Agents and Seamless Contextual Interactions to Accelerate Development

Vonage has released two Model Context Protocol (MCP) servers, now available across its developer ecosystem, including the Company’s 1.8 million registered developers, and discoverable by Postman’s global community of 40+ million developers through the Postman API Network:

Vonage Documentation MCP Server: Developers no longer need to leave their code editor to search documentation, SDKs, and sample code. The Vonage Documentation MCP Server lets developers ask questions in-line and receive context-aware answers and code they can integrate instantly from Vonage Documentation, reducing distractions and accelerating development.
Vonage MCP Tooling Server: Instead of only retrieving information, developers can have AI agents perform real actions - such as sending messages, managing numbers, checking balances, and more - within the tools their enterprise customers already use. This unlocks AI-driven automation, allowing developers to integrate the Tooling Server into their workflow and run SMS, voice, and WhatsApp operations directly from Claude, Cursor, VS Code Copilot, Antigravity, or similar environments.

“The cloud revolution made computing a programmable resource, and the API economy unlocked the same potential for software services. Now, the telecom network - the world's largest and most ubiquitous infrastructure - is becoming a programmable resource,” said Raul Castanon, Senior Research Analyst, 451 Research, S&P Global. “For developers, this transformation is a game-changer. It opens unprecedented opportunities to solve complex challenges through direct network access. From securing dedicated bandwidth for mission-critical applications, to enabling real-time SIM card verification to prevent fraud, developers who embrace and master network programming using APIs to build network powered solutions will be the architects of the next digital era, driving innovation and shaping the future of connected experiences.”¹

Equipping Startups to Succeed with Vonage Solutions

The Vonage Startup Program equips startups with the education, tools, and training to build transformative customer experiences with Vonage APIs, offering more support than any other startup program in the CPaaS industry to date. The program gives member businesses customised connectivity to Vonage APIs and accepted startups can leverage up to $75,000 in API credits over the first two years. With membership, developers can access Vonage APIs to connect with customers, build smarter products, engage users effortlessly, and grow a unique brand.

“We are thrilled to expand our offerings and developer relations programs,” said Alex Barnett, VP of Developer Ecosystem and Experience at Vonage. “Expanding our reach to an additional 40+ million developers through our verified Postman workspace - as well as the launch of our MCP servers and the benefits of the Vonage Startup Program - reflect our investment to being a leading partner to the global developer ecosystem. These initiatives enable developers to build next-generation digital solutions and expose new enterprise value.”

Follow the Vonage Developer LinkedIn Page for the latest news and information.

About Vonage

Vonage, a part of Ericsson, creates technology that empowers enterprises and equips developers to lead in the next era of digital transformation. Its AI-powered platforms and tools enable new value creation and innovative customer experiences across mobile networks and the cloud.

The company's technology portfolio includes Network APIs, CPaaS, CCaaS, and UCaaS solutions. Trusted by enterprises across industries and embraced by developers around the world, Vonage is committed to reimagining every digital interaction.

Vonage is a wholly-owned subsidiary of Ericsson (NASDAQ: ERIC) and operates within Ericsson Group Business Area Global Communications Platform (BGCP). For more information visit www.vonage.com and follow @Vonage.

¹ "In 2026, the telecom network becomes code”, 451 Research, S&P Global (January 27, 2026).

View source version on businesswire.com: https://www.businesswire.com/news/home/20260219628096/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom